Erratum: Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes (PLoS ONE (2015) 10:9 (e0136851) DOI: 10.1371/journal.pone.0136851)

Priscilla F. McAuliffe, Kurt W. Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M. Holder, Chandeshwar Sharma, Huiqin Chen, Kim Anh Do, Emily Tarco, Mihai Gagea, Katherine A. Naff, Aysegul Sahin, Asha S. Multani, Dalliah M. Black, Elizabeth A. Mittendorf, Isabelle BedrosianGordon B. Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish (US)
Article numbere0151121
JournalPLoS ONE
Volume11
Issue number3
DOIs
StatePublished - Mar 2016

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

McAuliffe, P. F., Evans, K. W., Akcakanat, A., Chen, K., Zheng, X., Zhao, H., Eterovic, A. K., Sangai, T., Holder, A. M., Sharma, C., Chen, H., Do, K. A., Tarco, E., Gagea, M., Naff, K. A., Sahin, A., Multani, A. S., Black, D. M., Mittendorf, E. A., ... Meric-Bernstam, F. (2016). Erratum: Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes (PLoS ONE (2015) 10:9 (e0136851) DOI: 10.1371/journal.pone.0136851). PLoS ONE, 11(3), [e0151121]. https://doi.org/10.1371/journal.pone.0151121